Response to Letter to the Editor concerning "Progression-free survival (PFS) in oncology: Caveat emptor!"

Troels K Bergmann^{1

2

3}, Mette Marie H Christensen^{2

3

4}, Maija Bruun Haastrup^{1

2}, Per Damkier^{2

4}

Affiliations

¹ Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
² Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
³ Hospital Pharmacy, Hospital of South West Denmark, Esbjerg, Denmark.
⁴ Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Free article

Comment

Troels K Bergmann et al. Basic Clin Pharmacol Toxicol. 2019 Mar.

Free article

. 2019 Mar;124(3):239.

doi: 10.1111/bcpt.13200.

Troels K Bergmann^{1

2

3}, Mette Marie H Christensen^{2

3

4}, Maija Bruun Haastrup^{1

2}, Per Damkier^{2

4}

¹ Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
² Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
³ Hospital Pharmacy, Hospital of South West Denmark, Esbjerg, Denmark.
⁴ Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

No abstract available

Comment on

Progression-free survival (PFS) in oncology: caveat emptor!
Sarac SB, Ainsworth MA, Hovgaard D, Bjerrum OW. Sarac SB, et al. Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):237-238. doi: 10.1111/bcpt.13192. Epub 2019 Jan 22. Basic Clin Pharmacol Toxicol. 2019. PMID: 30672131 No abstract available.